Main Article Content
Since ancient times, coffee has been one of the widely consumed beverages all over the world. It is renowned for its refreshing, body stimulating effect and unique taste. It belongs to the genus Coffea, class Dicotyledoneae, order Rubiales and family Rubiaceae. Coffee is a natural complex chemical mixture constituted of several compounds. It is accountable for numerous bioactivities and a number of compounds exhibit these effects. Some of the significant bioactivities documented are anti-oxidant, anti-mutagenic, anti-carcinogenic and anti-obesity properties. The varying constituents of coffee responsible for the chemo-protective effects are mainly polyphenols including chlorogenic acids and their degradation products. Others include caffeine, diterpenoid alcohols such as kahweol, cafestol and other phenolics. Coffee has been reported to exhibit both protective and adverse effects on various body systems such as skeletal (bone), reproductive, nervous and cardiovascular systems; homocysteine and cholesterol levels and so on. The present review provides an overview of the coffee and its constituents; and their relationship with various diseases. Recent investigations on its health benefits, with focus on their anti-cancer, anti-obesity properties and effect on cardiovascular diseases have also been discussed.
You DC, Kim YS, Ha AW, Lee YN, Kim SM, Kim CH, Lee JM. Possible health effects of caffeinated coffee consumption on Alzheimer’s disease and cardiovascular disease. Toxicological Research. 2011;27(1):7-10.
de Mejia EG, Ramirez-Mares MV. Impact of caffeine and coffee on our health. Trends in Endocrinology and Metabolism. 2014;25(10):489-492.
Higdon JV, Frei B. Coffee and health: a review of recent human research. Critical Reviews in Food Science and Nutrition. 2006;46(2):101-123.
Messina GIOVANNI, Zannella C, Monda V, Dato A, Liccardo D, De Blasio S, Monda M. The beneficial effects of coffee in human nutrition. Biology and Medicine. 2015;7(4):1.
Revuelta-Iniesta R, Al-Dujaili EA. Consumption of green coffee reduces blood pressure and body composition by influencing 11β-HSD1 enzyme activity in healthy individuals: a pilot crossover study using green and black coffee. BioMed Research International. 2014;2014.
Bharath N, Sowmya NK, Mehta DS. Determination of antibacterial activity of green coffee bean extract on periodontogenic bacteria like Porphyromonas gingivalis, Prevotella intermedia, Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans: An in vitro study. Contemporary Clinical Dentistry. 2015;6(2):166.
Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Critical Reviews in Food Science and Nutrition. 2011;51(4):363-373.
Cappelletti S, Daria P, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Current Neuropharmacology. 2015;13(1):71-88.
Glade MJ. Caffeine—not just a stimulant. Nutrition. 2010;26(10):932-938.
Chen S, Teoh NC, Chitturi S, Farrell GC. Coffee and non‐alcoholic fatty liver disease: Brewing evidence for hepatoprotection?. Journal of Gastroenterology and Hepatology. 2014;29(3):435-441.
El-Abhar HS, Schaalan MF. Phytotherapy in diabetes: Review on potential mechanistic perspectives. World Journal of Diabetes. 2014;5(2):176.
Gaascht F, Dicato M, Diederich M. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer. Genes and Nutrition. 2015;10(6):51.
Pan MH, Tung YC, Yang G, Li S, Ho CT. Molecular mechanisms of the anti-obesity effect of bioactive compounds in tea and coffee. Food and Function. 2016;7(11):4481-4491.
Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A. Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies. Journal of Alzheimer's Disease. 2010;20(s1):S221-S238.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose–response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643-659.
Gavrieli A, Karfopoulou E, Kardatou E, Spyreli E, Fragopoulou E, Mantzoros CS, Yannakoulia M. Effect of different amounts of coffee on dietary intake and appetite of normal‐weight and overweight/obese individuals. Obesity. 2013;21(6):1127-1132.
Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37(2):569-586.
Schmit SL, Rennert HS, Rennert G, Gruber SB. Coffee consumption and the risk of colorectal cancer. Cancer Epidemiology and Prevention Biomarkers. 2016;25(4):634-639.
George SE, Ramalakshmi K, Mohan Rao LJ. A perception on health benefits of coffee. Critical Reviews in Food Science and Nutrition. 2008;48(5):464-486.
Tofalo R, Renda G, De Caterina R, Suzzi G. Coffee: health effects. Encyclopedia of Food and Health. 2016;2:237-243.
Nosáľová G, Prisenžňáková L, Paulovičová E, Capek P, Matulová M, Navarini L, Liverani FS. Antitussive and immunomodulating activities of instant coffee arabinogalactan-protein. International Journal of Biological Macromolecules. 2011;49(4):493-497.
Şemen S, Mercan S, Yayla M, Açıkkol M. Elemental composition of green coffee and its contribution to dietary intake. Food Chemistry. 2017;215:92-100.
Akash MSH, Rehman K, Chen S. Effects of coffee on type 2 diabetes mellitus. Nutrition. 2014;30(7-8):755-763.
Volk BM, Creighton BC. An overview on caffeine. In nutrition and enhanced sports performance. 2013;487-495. Academic Press.
Gökcen BB, Şanlier N. Coffee consumption and disease correlations. Critical Reviews in Food Science and Nutrition. 2019;59(2):336-348.
Gaspar S, Ramos F. Caffeine: consumption and health effects. Encyclopedia of Food and Health. 2016;573-578. Academic Press Oxford.
Tazzeo T, Bates G, Roman HN, Lauzon A. M, Khasnis MD, Eto M, Janssen LJ. Caffeine relaxes smooth muscle through actin depolymerization. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2012;303(4):L334-L342.
Lee KA, Chae JI, Shim JH. Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma. Journal of Biomedical Science. 2012;19(1):60.
Kurzrock T, Speer K. Diterpenes and diterpene esters in coffee. Food Reviews International. 2001;17(4):433-450.
Penson P, Serban MC, Ursoniu S, Banach M. Does coffee consumption alter plasma lipoprotein [A] concentrations? A systematic review. Critical Reviews in Food Science and Nutrition. 2018;58(10):1706-1714.
Karabudak E, Türközü D, Köksal E. Association between coffee consumption and serum lipid profile. Experimental and Therapeutic Medicine. 2015;9(5):1841-1846.
Zhang C, Linforth R, Fisk ID. Cafestol extraction yield from different coffee brew mechanisms. Food Research International. 2012;49(1):27-31.
Silva JA, Borges N, Santos A, Alves A. Method validation for cafestol and kahweol quantification in coffee brews by HPLC-DAD. Food Analytical Methods. 2012;5(6):1404-1410.
Cárdenas C, Quesada AR, Medina MÁ. Insights on the antitumor effects of kahweol on human breast cancer: decreased survival and increased production of reactive oxygen species and cytotoxicity. Biochemical and Biophysical Research Communications. 2014;447(3):452-458.
Farah A, Monteiro M, Donangelo CM, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. The Journal of Nutrition. 2008;138(12):2309-2315.
Meng S, Cao J, Feng Q, Peng J, Hu Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evidence-Based Complementary and Alternative Medicine. 2013.
Loftfield E, Shiels MS, Graubard BI, Katki HA, Chaturvedi AK, Trabert B, Wentzensen N. Associations of coffee drinking with systemic immune and inflammatory markers. Cancer Epidemiology and Prevention Biomarkers. 2015;24(7):1052-1060.
Capek P, Matulová M, Navarini L, Suggi-Liverani F. Structural features of an arabinogalactan-protein isolated from instant coffee powder of Coffea arabica beans. Carbohydrate Polymers. 2010;80(1):180-185.
Capek P, Paulovičová E, Matulová M, Mislovičová D, Navarini L, Suggi-Liverani, F. Coffea arabica instant coffee—chemical view and immunomodulating properties. Carbohydrate Polymers. 2014;103:418-426.
Gostner JM, Schroecksnadel S, Jenny M, Klein A, Ueberall F, Schennach H, Fuchs D. Coffee extracts suppress tryptophan breakdown in mitogen-stimulated peripheral blood mononuclear cells. Journal of the American College of Nutrition. 2015; 34(3): 212-223.
Lopez-Garcia, E., Van Dam, R. M., Qi, L., and Hu, F. B. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. The American Journal of Clinical Nutrition. 2006;84(4):888-893.
International Agency for Research on Cancer. IARC Monographs evaluate drinking coffee, maté, and very hot beverages; 2016.
Hashibe M, Galeone C, Buys SS, Gren L, Boffetta P, Zhang ZF, La Vecchia C. Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort. British Journal of Cancer. 2015;113(5):809-816.
Park GH, Song HM, Jeong JB. The coffee diterpene kahweol suppresses the cell proliferation by inducing cyclin D1 proteasomal degradation via ERK1/2, JNK and GKS3β-dependent threonine-286 phosphorylation in human colorectal cancer cells. Food and Chemical Toxicology. 2016;95:142-148.
Fukushima Y, Tashiro T, Kumagai A, Ohyanagi H, Horiuchi T, Takizawa K, Sugihara N, Kishimoto Y, Taguchi C, Tani M, Kondo K. Coffee and beverages are the major contributors to polyphenol consumption from food and beverages in Japanese middle-aged women. Journal of Nutritional Science. 2014;3:e48.
Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer. 2011;11(1):1-11.
Chae JI, Jeon YJ, Shim JH. Anti‐proliferative properties of kahweol in oral squamous cancer through the regulation specificity protein 1. Phytotherapy Research. 2014;28(12):1879-1886.
Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the importance of context. Nature Reviews Cancer. 2012;12(8):564-571.
Volz N, Boettler U, Winkler S, Teller N, Schwarz C, Bakuradze T, Eisenbrand G, Haupt L, Griffiths LR, Stiebitz, H, Bytof, G, Lantz I, Lang R, Hofmann T, Somoza V, Marko D. Effect of coffee combining green coffee bean constituents with typical roasting products on the Nrf2/ARE pathway in vitro and in vivo. Journal of Agricultural and Food Chemistry. 2012;60(38):9631-9641.
Oh JK, Sandin S, Ström P, Löf M, Adami HO, Weiderpass E. Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden. International Journal of Cancer. 2015;137(8):1979-1989.
Bøhn SK., Blomhoff R, Paur I. Coffee and cancer risk, epidemiological evidence, and molecular mechanisms. Molecular Nutrition and Food Research. 2014;58(5):915-930.
Haggar FA, Boushey RP. Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clinics in Colon and Rectal Surgery. 2009;22(4):191-197.
Budhathoki S, Iwasaki M, Yamaji T, Sasazuki S, Tsugane S. Coffee intake and the risk of colorectal adenoma: The colorectal adenoma study in Tokyo. International Journal of Cancer. 2015;137(2):463-470.
Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Letters. 2009;277(2):121-125.
World Cancer Research Fund, and American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer: Colorectal Cancer 2011 report; 2011.
Mascitelli L, Goldstein MR. Inhibition of iron absorption by polyphenols as an anticancer mechanism. In Polyphenols in Human Health and Disease. 2014;1283-1286. Academic Press.
Kang NJ, Lee KW, Kim BH, Bode AM, Lee HJ, Heo YS, Boardman L, Limburg P, Lee HJ, Dong Z. Coffee phenolic phytochemicals suppress colon cancer metastasis by targeting MEK and TOPK. Carcinogenesis. 2011;32(6):921-928.
Ran HQ, Wang JZ, Sun CQ. Coffee consumption and pancreatic cancer risk: An update meta-analysis of cohort studies. Pakistan Journal of Medical Sciences. 2016;32(1):253-259.
WCRF/AICR. Food, Nutrition, Physical Activity, and the Prevention of Pancreatic Cancer. Pancreatic Cancer report; 2012. Available:http://wwwaicrorg/continuous-updateproject/ reports/pancreatic-cancer-2012-reportpdf.
Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, Bergkvist L, Freudenheim JL. Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer Epidemiology and Prevention Biomarkers. 2012;21(2):305-318.
Turati F, Galeone C, Edefonti V, Ferraroni M, Lagiou P, La Vecchia C, Tavani AA. meta-analysis of coffee consumption and pancreatic cancer. Annals of Oncology. 2012;23(2):311-318.
Bhoo–Pathy N, Uiterwaal CS, Dik VK, Jeurnink SM, Bech BH, Overvad K, Racine A. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition and Cancer Study. Clinical Gastroenterology and Hepatology. 2013;11(11):1486-1492.
Nie K, Xing Z, Huang W, Wang W, Liu W. Coffee intake and risk of pancreatic cancer: an updated meta-analysis of prospective studies. Minerva Medica. 2016;107(4):270-278.
Dong J, Zou J, Yu XF. Coffee drinking and pancreatic cancer risk: a meta-analysis of cohort studies. World Journal of Gastroenterology. 2011;17(9):1204-1210.
Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Current Pharmaceutical Biotechnology. 2012;13(1):218-228.
Wierzejska RW. Coffee consumption vs. cancer risk- a review of scientific data. Roczniki Państwowego Zakładu Higieny. 2015;66(4):293-298.
WCRF. Diet, nutrition, physical activity and liver cancer; 2015.
Masterton GS, Hayes PC. Coffee and the liver: a potential treatment for liver disease? European Journal of Gastroenterology and hepatology. 2010;22(11):1277-1283.
Sang LX, Chang B, Li XH, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterology. 2013;13(1):34.
Aleksandrova K, Bamia C, Drogan D, Lagiou P, Trichopoulou A, Jenab M, Tsilidis K. The association of coffee intake with liver cancer risk is mediated by biomarkers of inflammation and hepatocellular injury: Data from the European Prospective Investigation into Cancer and Nutrition. The American Journal of Clinical Nutrition. 2015;102(6):1498-1508.
Chinwe AAO, Johnkennedy N, Hope O, Constance O, Helen U. The effect of coffee consumption on liver enzymes and bilirubin in healthy subjects. Journal of Current Research in Science. 2013;1(2):104-108.
Manne V, Saab S. Coffee as modulator of liver injury: Fact and fiction. Clinical Liver Disease. 2015;(6):139-141.
Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Archives of Internal Medicine. 2006;166(11):1190-1195.
Pathy NB, Peeters P, Van Gils C, Beulens JWJ, Van Der Graaf Y, Bueno-de-Mesquita B, Bulgiba A, Uiterwaal CS. Coffee and tea intake and risk of breast cancer. Breast Cancer Research and Treatment. 2010;121(2):461-467.
Li J, Seibold P, Chang-Claude J, Flesch-Janys D, Liu J, Czene K, Humphreys K. Hall P. Coffee consumption modifies risk of estrogen-receptor negative breast cancer. Breast Cancer Research. 2011;13(3):R49.
Jiang W, Wu Y, Jiang X. Coffee and caffeine intake and breast cancer risk: an updated dose–response meta-analysis of 37 published studies. Gynecologic Oncology. 2013;129(3):620-629.
Ganmaa D, Willett WC, Li TY, Feskanich D, van Dam RM, Lopez‐Garcia E, Hunter DJ, Holmes MD. Coffee, tea, caffeine and risk of breast cancer: a 22‐year follow‐up. International Journal of Cancer. 2008;122(9):2071-2076.
Fagherazzi G, Touillaud MS, Boutron-Ruault MC, Clavel-Chapelon F, Romieu I. No association between coffee, tea or caffeine consumption and breast cancer risk in a prospective cohort study. Public Health Nutrition. 2011;14(7):1315-1320.
Li G, Ma D, Zhang Y, Zheng W, Wang P. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public Health Nutrition. 2013;16(2):346-357.
WCRF/AICR. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer: Breast Cancer; 2010 Report. Available:http://wwwaicrorg/continuous-updateproject/ reports/Breast-Cancer-2010-Reportpdf
Jernström H, Klug TL, Sepkovic DW, Bradlow HL, Narod SA. Predictors of the plasma ratio of 2-hydroxyestrone to 16α-hydroxyestrone among pre-menopausal, nulliparous women from four ethnic groups. Carcinogenesis. 2003;24(5):991-1005.
Nkondjock A, Ghadirian P, Kotsopoulos J, Lubinski J, Lynch H, Kim‐Sing C, Horsman D, Rosen B, Isaacs C, Weber B, Foulkes W, Ainsworth P, Tung N, Eisen A, Friedman E, Eng C, Sun P, Narod SA. Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers. International Journal of Cancer. 2006;118(1):103-107.
Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P. Narod SA. The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiology and Prevention Biomarkers. 2007;16(5):912-916.
Cao S, Liu L, Yin X, Wang Y, Liu J, Lu Z. Coffee consumption and risk of prostate cancer: a meta-analysis of prospective cohort studies. Carcinogenesis. 2014;35(2):256-261.
Wilson KM, Kasperzyk JL, Rider JR, Kenfield S, van Dam RM, Stampfer MJ, Giovannuci E, Mucci LA. Coffee consumption and prostate cancer risk and progression in the Health Professionals Follow-up Study. Journal of the National Cancer Institute. 2011;103(11):876-884.
Lu Y, Zhai L, Zeng J, Peng Q, Wang J, Deng Y, Xie L, Mo C, Yang S, Li S, Qin X. Coffee consumption and prostate cancer risk: an updated meta-analysis. Cancer Causes and Control. 2014;25(5):591-604.
Liu H, Hu GH, Wang XC, Huang TB, Xu L., Lai P, Guo ZF, Xu YF. Coffee consumption and prostate cancer risk: a meta-analysis of cohort studies. Nutrition and Cancer. 2015;67(3):392-400.
Tverdal A. Boiled coffee consumption and the risk of prostate cancer: follow-up of 224,234 Norwegian men 20–69 years. British Journal of Cancer. 2015;112(3):576-579.
Geybels MS, Neuhouser ML, Wright JL, Stott-Miller M, Stanford JL. Coffee and tea consumption in relation to prostate cancer prognosis. Cancer Causes and Control. 2013;24(11):1947-1954.
Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, Sinha R, Freedman ND. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. British Journal of Cancer. 2013;109(5):1344-1351.
Kamiyama M, Moon JK, Jang HW, Shibamoto T. Role of degradation products of chlorogenic acid in the antioxidant activity of roasted coffee. Journal of Agricultural and Food Chemistry. 2015;63(7):1996-2005.
Lee WJ, Zhu BT. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis. 2006;27(2):269-277.
Zhou Q, Luo M-L, Li H, Li M, Zhou J-G. Coffee consumption and risk of endometrial cancer: a dose-response meta-analysis of prospective cohort studies. Scientific Reports. 2015;5:13410. DOPI:10.1038/srep13410).
Yew YW, Lai YC, Schwartz RA. Coffee Consumption and melanoma: a systematic review and meta-analysis of observational studies. American Journal of Clinical Dermatology. 2016;17:113-123. DOI:10.1007/s40257-015-0165-1)
Wang A, Wang S, Zhu C, Huang H, Wu L, Wan X, Yang X, Zhang H, Miao R, He L, Sang X. Coffee and cancer risk: A meta-analysis of prospective observational studies. Scientific Reports. 2016;6:33711.
Caini S, Cattaruzza S, Bendinelli B, Tosti G, Masala G, Gnagnarella P, Assedi M, Stanganelli I, Palli D, Gandini S. Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis. European journal of nutrition. 2017;56(1):1-2.
Zeegers MP, Tan FE, Goldbohm RA, van den Brandt PA. Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis. International journal of epidemiology. 2001;30(2):353-362.
Prakash KM, Tan EK. Clinical evidence linking coffee and tea intake with Parkinson’s disease. Basal Ganglia. 2011;1(3):127-130.
Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of Parkinson's disease. Movement disorders: Official Journal of the Movement Disorder Society. 2007;22(15):2242-2248.
Martyn C, Gale C. Tobacco, coffee, and Parkinson's disease: Caffeine and nicotine may improve the health of dopaminergic systems. BMJ. 2003;326(7389):561-562.
Derkinderen P, Shannon KM, Brundin P. Gut feelings about smoking and coffee in Parkinson's disease. Movement Disorders. 2014;29(8):976-979.
Larsson SC, Orsini N. Coffee consumption and risk of stroke: A dose-response meta-analysis of prospective studies. American Journal of Epidemiology. 2011;174(9):993–1001.
Van Dam RM, Willett WC, Manson JE, Hu FB. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged US women. Diabetes Care. 2006;29(2):398-403.
Alperet DJ, Rebello SA, Khoo EYH, Tay Z, Seah SSY, Tai BC, Emady-Azar S, Chou CJ, Darimont C, van Dam RM. A randomized placebo-controlled trial of the effect of coffee consumption on insulin sensitivity: Design and baseline characteristics of the Coffee for METabolic Health [COMETH] study. Contemporary Clinical Trials Communications. 2016;4:105-117.
Fernandez-Gomez B, Lezama A, Amigo-Benavent M, Ullate M, Herrero M, Martín MÁ, Mesa MD, del Castillo MD. Insights on the health benefits of the bioactive compounds of coffee silverskin extract. Journal of Functional Foods. 2016;25:197-207.
Muley A, Muley P, Shah M. Coffee to reduce risk of type 2 diabetes?: a systematic review. Current Diabetes Reviews. 2012;8(3):162-168.
Pimentel GD, Zemdegs JC, Theodoro JA, Mota JF. Does long-term coffee intake reduce type 2 diabetes mellitus risk?. Diabetology and Metabolic Syndrome. 2009;1(1):6.
Pereira MA, Parker ED, Folsom AR. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28812 postmenopausal women. Archives of Internal Medicine. 2006;166(12):1311-1316.
Santos RMM, Lima DRA. Coffee consumption, obesity and type 2 diabetes: a mini-review. European Journal of Nutrition. 2016;55(4):1345-1358.
Van Dam RM, Feskens EJ. Coffee consumption and risk of type 2 diabetes mellitus. The Lancet. 2002;360(9344):1477-1478.
Yarmolinsky J, Mueller NT, Duncan BB, Bisi Molina MDC, Goulart AC, Schmidt MI. Coffee consumption, newly diagnosed diabetes, and other alterations in glucose homeostasis: a cross-sectional analysis of the longitudinal study of adult health [ELSA-Brasil]. PLoS One. 2015;10(5):e0126469.
Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37(2):569-586.
Bøhn SK, Ward NC, Hodgson JM, Croft KD. Effects of tea and coffee on cardiovascular disease risk. Food and Function. 2012;3(6):575-591.
Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Current Opinion in Lipidology. 2007;18(1): 13-19.
Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. The American Journal of Clinical Nutrition. 2001;73(3):532-538.
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutrition Journal. 2015;14(1):1-10.
O'Keefe JH, Bhatti SK, Patil HR, Dinicolantonio JJ, Lucan SC, Lavie CJ. Effects of habitual coffee consumption on cardiometabolic disease, cardiovascular health, and all-cause mortality. Journal of the American College of Cardiology. 2013;62(12):1043-1051.
Geleijnse JM. Habitual coffee consumption and blood pressure: an epidemiological perspective. Vascular Health and Risk Management. 2008;4(5):963.
Farag NH, Whitsett TL, McKey BS, Wilson MF, Vincent AS, Everson-Rose SA, Lovallo WR. Caffeine and blood pressure response: sex, age, and hormonal status. Journal of Women's Health. 2010;19(6):1171-1176.
Shateri Z, Djafarian K. Coffee consumption and coronary heart diseases: A Mini-Review. Journal of Clinical Nutrition and Dietetics. 2016;2:1.
Bidel S, Tuomilehto J. Coffee and cardiovascular diseases. Coffee: Emerging Health Effects and Disease Prevention. 2012;59:181-195.
Jee SH, He J, Appel LJ, Whelton PK, Suh II, Klag MJ. Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. American Journal of Epidemiology. 2001;153(4):353-362.
Naidoo N, Chen C, Rebello SA et al. Cholesterol-raising diterpenes in types of coffee commonly consumed in Singapore, Indonesia and India and associations with blood lipids: A survey and cross sectional study. Nutrition Journal. 2011;10: 48. Available:https://doi.org/10.1186/1475-2891-10-48.
Dias RCE, de Faria-Machado AF, Mercadante AZ, Bragagnolo N, de Toledo Benassi M. Roasting process affects the profile of diterpenes in coffee. European Food Research and Technology. 2014;239(6):961-970.
Steffen M, Kuhle C, Hensrud D, Erwin PJ, Murad MH. The effect of coffee consumption on blood pressure and the development of hypertension: a systematic review and meta-analysis. Journal of Hypertension. 2012;30:2245-2254. DOI:10.1097/HJH.0b013e3283588d73.
Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation 2014;129:643-659. DOI:10.1161/CIRCULATIONAHA.113.005925.
Grosso G, Micek A, Godos J, et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. European Journal of Epidemiology. 2016;31:1191-1205. DOI:10.1007/s10654-016-0202-2.
Cai L, Ma D, Zhang Y, Liu Z, Wang P. The effect of coffee consumption on serum lipids: a meta-analysis of randomized controlled trials. European Journal of Clinical Nutrition. 2012;66:872-877. DOI:10.1038/ejcn.2012.68
Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. American Journal of Physiology-Endocrinology and Metabolism. 2011;300(1):E122-E133
Nagao T, Ochiai R, Watanabe T, Kataoka K, Komikado M, Tokimitsu I, Tsuchida T. Visceral fat-reducing effect of continuous coffee beverage consumption in obese subjects. Japanese Pharmacology and Therepeitics. 2009;37(4):333-344.
Shimoda H, Seki E, Aitani M. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complementary and Alternative Medicine. 2006;6(1):9.
Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food and Chemical Toxicology. 2010;48(3):937-943.
Song F, Oh J, Lee K, Cho MS. The effect of coffee consumption on food group intake, nutrient intake, and metabolic syndrome of Korean adults—2010 KNHANES [V-1]. NFS Journal. 2016;4:9-14.
Nordestgaard AT, Thomsen M, Nordestgaard BG. Coffee intake and risk of obesity, metabolic syndrome and type 2 diabetes: a Mendelian randomization study. International Journal of Epidemiology. 2015;44(2):551-565.
Onakpoya I, Terry R, Ernst E. The use of green coffee extract as a weight loss supplement: a systematic review and meta-analysis of randomised clinical trials. Gastroenterology Research and Practice. 2011;2011:382852.
Choi BK, Park SB, Lee DR, Lee HJ, Jin YY, Yang SH, Suh JW. Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-induced obese mice. Asian Pacific Journal of Tropical Medicine. 2016;9:635-643.
Garrett Oden. The Ultimate Guide To Coffee And Health; 2020 Edition. Available:https://www.javapresse.com/blogs/enjoying-coffee/the-ultimate-guide-to-coffee-and-health
Grosso G, Micek A, Godos J et al. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. European journal of epidemiology. 2016;1191-1205.
Wijarnpreecha K, Thongprayoon C, Ungprasert P. Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. European Journal of Gastroenterology and Hepatology. 2017;29:e8-12.
Liu F, Wang X, Wu G, et al. Coffee consumption decreases risks for hepatic Fibrosis and Cirrhosis: A Meta-Analysis. PLoS One 2015;10:e0142457 DOI:10.1371/journal.pone.0142457.
Grosso G, Micek A, Castellano S, Pajak A, Galvano F. Coffee, tea, caffeine and risk of depression: A systematic review and dose-response meta-analysis of observational studies. Molecular Nutrition and Food Research. 2016;60:223-234. DOI:10.1002/mnfr.201500620.
Lee DR, Lee J, Rota M, Lee J, Ahn HS, Park SM, Shin D. Coffee consumption and risk of fractures: a systematic review and dose- response meta-analysis. Bone 2014;63:20-28.
Lee YH, Bae S-C, Song GG. Erratum to: Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis. Clinical Rheumatology. 2015;34:403-5. DOI:10.1007/s10067-014-2851-4.
Guillán-Fresco M, Franco-Trepat E, Alonso-Pérez A, Jorge-Mora A, López-Fagúndez M, Pazos-Pérez A, Gualillo O, Gómez R. Caffeine, a risk factor for osteoarthritis and longitudinal bone growth inhibition. Journal of clinical medicine. 2020;9(4):1163.
Wang S, Zhang Y, Mao Z, He X, Zhang Q, Zhang D. A meta-analysis of coffee intake and risk of urolithiasis. Urologia Internationalis. 2014;93:220-228. DOI:10.1159/000356559.
Sun S, Liu D, Jiao Z. Coffee and caffeine intake and risk of urinary incontinence: a meta-analysis of observational studies. BMC Urology. 2016;16:61 DOI:10.1186/s12894-016-0178-y
Wijarnpreecha K, Thongprayoon C, Thamcharoen N, Panjawatanan P, Cheungpasitporn W. Association of coffee consumption and chronic kidney disease: A meta-analysis. International Journal of Clinical Practice. 2017;71:e12919. DOI:10.1111/ijcp.12919.
Zhang Y-P, Li WQ, Sun YL, Zhu RT, Wang WJ. Systematic review with meta-analysis: coffee consumption and the risk of gallstone disease. Aliment Pharmacology and Therapeutics. 2015;42:637-648. DOI:10.1111/apt.13328
Rhee J, Kim R, Kim Y, et al. Maternal Caffeine Consumption during Pregnancy and Risk of Low Birth Weight: A Dose-Response Meta-Analysis of Observational Studies. PLoS One 2015;10:e0132334. DOI:10.1371/journal.pone.0132334.
Li J, Zhao H, Song JM, Zhang J, Tang YL, Xin CM. A meta-analysis of risk of pregnancy loss and caffeine and coffee consumption during pregnancy. International Journal of Gynaecology and Obstetrics. 2015;130:116-122. DOI:10.1016/j.ijgo.2015.03.033
Thomopoulos TP, Ntouvelis E, Diamantaras AA, Tzanoudaki M, Baka M, Hatzipantelis E, Kourti M, Polychronopoulou S, Sidi V, Stiakaki E, Moschovi M. Maternal and childhood consumption of coffee, tea and cola beverages in association with childhood leukemia: a meta-analysis. Cancer epidemiology. 2015;39(6):1047-1059.
Maslova E, Bhattacharya S, Lin S-W, Michels KB. Caffeine consumption during pregnancy and risk of preterm birth: a meta-analysis. American Journal of Clinical Nutrition. 2010;92:1120-1132. DOI:10.3945/ajcn.2010.29789.
EFSA Panel on Dietetic Products and Allergies. Scientific opinion on the safety of caffeine. EFSA Journal. 2015;13(5).